However, in a different series the prevalence of PTEN mutations in primary RCC tumors was extremely variable (ranging from 4% to 42%), thus making it difficult to attribute a prognostic role to PTEN gene status. The gene discussed is PTEN; the disease is renal cell carcinoma.